Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | ||
Age | 1082 | Â | Â | Â | Â |
  ≤ 60 | 601 | Reference |  |  |  |
  > 60 | 481 | 2.020 (1.465–2.784) |  < 0.001 | 3.154 (1.616–6.155) |  < 0.001 |
T stage | 1079 | Â | Â | Â | Â |
 T1 | 276 | Reference |  |  |  |
 T2 | 629 | 1.332 (0.887–1.999) | 0.166 | 1.013 (0.520–1.973) | 0.970 |
 T3&T4 | 174 | 1.953 (1.221–3.123) | 0.005 | 1.649 (0.683–3.982) | 0.266 |
N stage | 1063 | Â | Â | Â | Â |
 N0 | 514 | Reference |  |  |  |
 N1 | 357 | 1.956 (1.329–2.879) |  < 0.001 | 1.376 (0.702–2.697) | 0.352 |
 N2 | 116 | 2.519 (1.482–4.281) |  < 0.001 | 2.985 (1.297–6.869) | 0.010 |
 N3 | 76 | 4.188 (2.316–7.574) |  < 0.001 | 6.068 (2.364–15.573) |  < 0.001 |
M stage | 922 | Â | Â | Â | Â |
 M0 | 902 | Reference |  |  |  |
 M1 | 20 | 4.254 (2.468–7.334) |  < 0.001 | 3.639 (1.152–11.498) | 0.028 |
ER status | 1032 | Â | Â | Â | Â |
 Negative | 240 | Reference |  |  |  |
 Positive | 792 | 0.712 (0.495–1.023) | 0.066 | 0.469 (0.189–1.164) | 0.102 |
PR status | 1029 | Â | Â | Â | Â |
 Negative | 342 | Reference |  |  |  |
 Positive | 687 | 0.732 (0.523–1.024) | 0.068 | 1.028 (0.440–2.403) | 0.948 |
HER2 status | 715 | Â | Â | Â | Â |
 Negative | 558 | Reference |  |  |  |
 Positive | 157 | 1.593 (0.973–2.609) | 0.064 | 0.931 (0.476–1.821) | 0.836 |
Menopause status | 931 | Â | Â | Â | Â |
 Pre | 229 | Reference |  |  |  |
 Post | 702 | 2.165 (1.302–3.600) | 0.003 | 2.083 (0.863–5.032) | 0.103 |